株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のアフェレーシス市場:用途、タイプ、技術、地域別 - 成長、動向、予測

Apheresis Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 390877
出版日 ページ情報 英文 118 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.67円で換算しております。
Back to Top
世界のアフェレーシス市場:用途、タイプ、技術、地域別 - 成長、動向、予測 Apheresis Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年02月01日 ページ情報: 英文 118 Pages
概要

アフェレーシスは、多様な疾患の緊急治療法として受け入れられており、何百万人もの患者が毎年アフェレーシス療法を受けています。今日、アフェレーシス療法は、関節リウマチ、癌、多発性硬化症などの慢性疾患に対する治療法のひとつとして認識されています。世界のアフェレーシス市場は、調査期間の2018年から2023年にかけて約7.7%のCAGRで推移することが予測されています。

当レポートでは、世界のアフェレーシス市場を調査し、市場の概要、用途・タイプ・技術・地域別の市場動向、市場規模の推移と予測、成長要因・阻害要因ならびに市場機会・課題の予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 現在の市場シナリオ
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第6章 成長要因、阻害要因、市場機会、課題の分析(DROC)

  • 成長要因
    • 疾病の罹患率の上昇と事故の増加
    • 血液成分と安全性に対する需要の増加
    • 新たなアフェレーシス療法の開発技術の向上
    • 償還制度と資金調達
  • 阻害要因
    • 高い設備投資と治療コスト
    • 有資格者の不足
    • 血液汚染のリスク
  • 市場機会
  • 主な課題

第7章 世界のアフェレーシス市場:セグメント別

  • 製品別
    • 機器
    • 消耗品
  • タイプ別
    • 白血球除去療法
    • 血漿浄化療法
    • 血小板除去療法
    • 赤血球採取法
    • その他
  • 技術別
    • 遠心分離法
    • 膜分離法
  • 用途別
    • 腎障害
    • 血液疾患
    • 神経疾患
    • 自己免疫疾患
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第8章 競合情勢

  • 合併・買収分析
  • 合意・協力・提携
  • 新製品の上市

第9章 主要企業のプロファイル

  • 旭化成
  • B. Braun Melsungen AG
  • Cerus Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • カネカ
  • 川澄化学
  • テルモ
  • Therakos Inc

第10章 市場の将来展望

目次
Product Code: 60458

Market Overview

The propelling factors for the growth of the apheresis market include the increasing number of diseases, a rise in the demand for blood components and associated safety, technological advancement in the development of new apheresis techniques, and rise in the reimbursement policies and funding for apheresis procedures. Due to the aforementioned factors, the apheresis market is expected to experience a boost during the forecast period.

With the increasing number of surgeries and surgical techniques, advanced treatments have led to global demand for blood and the blood components. The need for blood components is significantly growing and contributing to healthcare spending. Apheresis has also recently witnessed a high demand due to an increased number of patients suffering from various ailments related to blood, kidney, metabolic diseases, and neurological disorders. Therefore, apheresis technology is used to reduce the number of white cells, until other medications can control them. With the steady increase in the number of patients suffering from these diseases, ailments, and the technical ease of using these devices in the treatment of these diseases, requiring a minimal hospital stay, the global apheresis market is poised to experience growth during the forecast period.

The use of apheresis in clinically ill patients is increasing day by day, and it has been widely used as the primary therapy or as an adjunct to other treatments for various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure.

Therefore with the steady increase in the number of patients suffering from these diseases, ailments, and the technical ease of using these devices in the treatment of these diseases, thus requiring a minimal hospital stay, the global apheresis market is poised to experience growth during the forecast period.

The Scope of the Report

As per the scope of the report, apheresis is a medical technique where the blood of an individual, be a donor or a patient, is passed through an apparatus that segregates out a particular constituent and returns the rest to the blood circulation. It involves blood purification and blood component separation by using centrifugation or membrane filtration technology. This procedure is performed for blood donation component or for the treatment of disease.

Key Market Trends

Hematological Disorders is the Segment under Application that is Expected to Grow Fastest during the Forecast Period

Hematological disorders are found common in low-income countries, and they make a substantial contribution to morbidity and mortality of individuals in these regions. Hence, owing to the increasing burden of hematological incidences and growing applications of apheresis as a treatment method for hematological disorders, the apheresis market for hematological disorders is expected to experience growth in the forecast period.

The recent years brought about a rise in new options of therapeutic apheresis, such as immunoadsorption, double filtration and cytapheresis used in the treatment of both primary and secondary autoimmune renal diseases. Those methods, more selective and safer than the classic TA, are potentially more efficient in the removal of pathogens, thus reducing the intoxication of the patient's organism.

Asia-Pacific holds the Fastest Growth and is Expected to follow the Same Trend over the Forecast Period

The Asia-Pacific region is predicted to witness high growth, owing to the rising geriatric population and the increasing prevalence of several choric diseases. China is found to be one of the largest consumers and manufacturers in the global plasma-derived products market and serves a vast population. Great progress has been made in the Chinese plasma fractionation industry in the past 50 years. Moreover, increasing healthcare expenditure is another critical factor that is likely to enhance the growth of the market in the near future.

Competitive Landscape

The market studied is dominated by a few major players, and currently, the market is well established in many areas and has shown nascent success history. However, its full potential is yet to be determined in the developing regions. With increasing government initiatives, there is an awareness among people, which is further driving the growth of the market studied.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Global Disease Burden
    • 4.2.2 Rise in Demand for Blood Components and Associated Safety
    • 4.2.3 Technological Advancement in Development of New Apheresis Techniques
    • 4.2.4 Rise in the Reimbursement Policies and Funding for Apheresis Procedures
  • 4.3 Market Restraints
    • 4.3.1 High Capital Investment and Costs Associated with Apheresis Procedures
    • 4.3.2 Lack of Qualified Skilled Professionals
    • 4.3.3 Risk of Blood Contamination
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Devices
    • 5.1.2 Disposables
      • 5.1.2.1 Interventional/Surgical Simulators
  • 5.2 By Apheresis Procedure
    • 5.2.1 Leukapheresis
    • 5.2.2 Plasmapheresis
    • 5.2.3 Plateletpheresis
    • 5.2.4 Erythrocytapheresis
    • 5.2.5 Other Apheresis Procedures
  • 5.3 By Technology
    • 5.3.1 Centrifugation
    • 5.3.2 Membrane Separation
  • 5.4 By Application
    • 5.4.1 Renal Disorders
    • 5.4.2 Hematological Disorders
    • 5.4.3 Neurological Disorders
    • 5.4.4 Autoimmune Disorders
    • 5.4.5 Other Applications
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Asahi Kasei Corporation
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Cerus Corporation
    • 6.1.4 Fresenius SE & Co. KGaA
    • 6.1.5 Haemonetics Corporation
    • 6.1.6 HemaCare Corporation
    • 6.1.7 Kaneka Corporation
    • 6.1.8 Kawasumi Laboratories Inc.
    • 6.1.9 Terumo Corporation
    • 6.1.10 Therakos Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top